P Ramarao Selected Research

P Ramarao Research Topics

Disease

5	Body Weight (Weight, Body) 01/2008 - 03/2002
4	Insulin Resistance 01/2010 - 04/2003
3	Rheumatoid Arthritis 01/2010 - 08/2008
3	Hyperinsulinism (Hyperinsulinemia) 01/2010 - 06/2004
3	Hypertension (High Blood Pressure) 09/2007 - 01/2001
3	Hyperglycemia 10/2005 - 04/2003
2	Neoplasms (Cancer) 04/2013 - 01/2010
2	Obesity 11/2009 - 06/2004
2	Type 2 Diabetes Mellitus (MODY) 11/2009 - 10/2005
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2009 - 08/2008
1	Hyperplasia 01/2010
1	Hyperlipidemias (Hyperlipidemia) 11/2009
1	Arthritis (Polyarthritis) 02/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Chronic Disease (Chronic Diseases) 09/2007
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2005
1	Alzheimer Disease (Alzheimer's Disease) 01/2005
1	Dementia (Dementias) 01/2005
1	Epilepsy (Aura) 01/2005
1	Parkinson Disease (Parkinson's Disease) 01/2005
1	Wounds and Injuries (Trauma) 01/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2005
1	Substance-Related Disorders (Drug Abuse) 01/2005
1	Stroke (Strokes) 01/2005
1	Chronic Pain 01/2005
1	Hypertriglyceridemia 06/2004
1	Glucose Intolerance 06/2004
1	Hypercholesterolemia 06/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2003
1	Diabetes Mellitus 03/2002
1	Pain (Aches) 03/2002
1	Diarrhea 03/2002
1	Diabetes Complications 10/2001
1	Hypothermia 05/2001
1	Tachycardia (Tachyarrhythmias) 03/2000

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2008 - 01/2001
4	Insulin (Novolin)FDA Link 01/2010 - 06/2004
3	Methotrexate (Mexate)FDA LinkGeneric 01/2010 - 08/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2010 - 04/2003
3	Triglycerides (Triacylglycerol)IBA 10/2005 - 06/2004
3	CholesterolIBA 10/2005 - 06/2004
2	Hormones (Hormone)IBA 04/2013 - 01/2001
2	Pioglitazone (Actos)FDA Link 01/2010 - 06/2004
2	AntioxidantsIBA 11/2009 - 09/2007
2	coenzyme Q10 (CoQ10)IBA 11/2009 - 09/2007
2	neodymium pyrocatechin disulfonate (NPD)IBA 10/2005 - 02/2005
2	polyherbal formulation Immu-21IBA 04/2003 - 03/2002
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2013
1	Peptides (Polypeptides)IBA 04/2013
1	Dihydrotachysterol (AT 10)IBA 11/2009
1	PolymersIBA 11/2009
1	Ellagic AcidIBA 11/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2009
1	Estrogens (Estrogen)FDA Link 01/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2009
1	Pharmaceutical PreparationsIBA 08/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2005
1	AdamantaneIBA 01/2005
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2005
1	Memantine (Namenda)FDA Link 01/2005
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2003
1	PPAR gammaIBA 04/2003
1	ThiazolidinedionesIBA 04/2003
1	beta Adrenergic ReceptorsIBA 03/2002
1	Opioid Analgesics (Opioids)IBA 03/2002
1	Cholinergic Agents (Cholinergics)IBA 03/2002
1	Aldehyde Reductase (Aldose Reductase)IBA 10/2001
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2001
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 05/2001
1	Serotonin (5 Hydroxytryptamine)IBA 05/2001
1	TM 1IBA 03/2000
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2000

Therapy/Procedure

4	Therapeutics 02/2009 - 01/2005
2	Drug Therapy (Chemotherapy) 04/2013 - 01/2010
2	Analgesia 03/2002 - 05/2001